Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stone Bond Technologies is a software company specializing in data virtualization and enterprise data integration, with a significant focus on the life sciences and healthcare sectors. Its flagship platform, Enterprise Enabler, provides a no-code environment that allows organizations to federate and integrate disparate data sources—such as clinical trial data, genomic information, and electronic health records—in real-time. By eliminating the need for traditional ETL processes, the company enables researchers and pharmaceutical firms to create a unified view of complex data sets, accelerating drug discovery and clinical development. The technology is particularly valued for its ability to handle CDISC standards and complex laboratory information management systems (LIMS). In early 2024, Stone Bond Technologies was acquired by Informatica to enhance its industry-specific data management and integration capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stone Bond Technologies.